Articles

Vanderbilt-Ingram Cancer Center received an overall “exceptional” score for its research impact and excellence in patient care. This achievement merits renewed funding from the National Cancer Institute and places it once again in a top group of NCI Comprehensive Cancer Centers.

VICC Receives ‘Exceptional’ Score With Renewal as an NCI-Designated Comprehensive Cancer Center

Although most younger patients received diagnoses of cancer of the rectum or distal colon, incidence rates are increasing across all colorectal anatomic subsites. 

Palliative Care for Young Adults Is a Growing Reality in CRC

Videos

Douglas B. Johnson, MD, MSCI, discusses the need to identify novel biomarkers in melanoma.








Dr. Johnson on the Need for Novel Biomarkers in Melanoma 

Leora Horn, MD, MSc, FRCPC, discusses the role of mobocertinib in patients with non​–small cell lung cancer.

Dr. Horn on the Role of Mobocertinib in NSCLC 

Douglas B. Johnson, MD, MSCI, discusses the limitations of biomarkers in melanoma.

Dr. Johnson on the Limitations of Biomarkers in Melanoma 

Jordan D. Berlin, MD, discusses the importance of more data and more effective treatment regimens in 
metastatic pancreatic cancer, despite the number of treatment options currently available. 

Vanderbilt-Ingram Cancer Center

Latest from Vanderbilt-Ingram Cancer Center

New content coming soon, please check back later.